FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for metoprolol succinate from Nivagen Pharmaceuticals, Inc., authorizing changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure
• Hypertension

Drugs mentioned

• Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

SUPPL AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)